ACE2 and cardiovascular disorder: In addition, the pathogen of COVID-19, SARS-COV-2, is mainly bound to target cells by angiotensin-converting enzyme 2(ACE2) and ACE1 drugs are often used in cardiovascular disease patients, and long-term use of ACE1 can up-regulate the expression of ACE2 receptors in the body [14].